Hosted on MSN1mon
Cumberland Pharma Stock Hits 16-Month High After FDA Approves Liver Drug Regimen: Retail’s ThrilledShares of Cumberland Pharmaceuticals (CPIX) doubled on Tuesday morning, reaching levels not seen since March 2023, following FDA approval of a new dosing regimen for its liver drug, Acetadote.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback